PRKN and Parkinson disease: For example, Leucine-rich repeat kinase 2 (LRRK2) and Parkin RBR E3 ubiquitin–protein ligase (PARK2) mutations contribute to the PD spectrum but exhibit phenotypic variability [34,201].